Verenium

Verenium engages in the development and commercialization of enzymes for industrial processes.

Business Model:

Revenue: $53.4M

Employees: 51-200

Detailed Verenium Information

Verenium was acquired by BASF.
The acquisition happend on 2013-09-27.
Details of the transaction were not public

Acquirer

Geographic Data

Verenium headquarters map

Address: 100 Park Ave

City: Florham Park

State: NJ

Zip: 07932

Country: US

Financial Info

Stage:

debt financing

Raised Last:

$23M

Raised Total:

$113M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Verenium engages in the development and commercialization of enzymes for industrial processes.

Contact Phone:
+19732456013

Contact Email:

Verenium went public on the NASDAQ

Listed Exchange:
NASDAQ

Ticker Symbol:
VRNM

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2012 Debt Financing 1 $22.5M Athyrium Capital Management LP
Athyrium Capital Management LP
2/2000 IPO $174M
8/2008 Venture Round 1 $90M BP
BP
BP
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research